Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Registration - 2003 > AccusStandard Inc

Notices of Registration - 2003


[Federal Register: October 7, 2003 (Volume 68, Number 194)]
[Notices]
[Page 57928-57929]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07oc03-87]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated June 6, 2003, and published in the Federal Register on June 19, 2003, (68 FR 26841), AccusStandard Inc., 125 Market Street, New Haven, Connecticut 06513, made application by renewal and on May 7, 2003, by letter to the Drug Enforcement Administration to be registered as a bulk manufacturer of the basic classes of Schedule I and II controlled substances listed below: 

Drug  Schedule
Cathinone (1235) I
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
Fenethylline (1503) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) (1590) I
Gamma hydroxybutyric acid (2010) I
Methaqualone (2565) I
Mecloqualone (2372) I
Alpha-Ethyltryptamine (7249) I
Ibogaine (7260) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxymphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,5-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenediocy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
Befotenine (7433) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
Psilocybin (7437) I
Psilocyn (7438) I
N-Ethyl-1-phenylcyclohexylamine (7455) I
1-(1-Phenylcyclohexyl) pyrrolidine (PCPY) (7458) I
Noracymethadol (9633) I
Norlevorphanol (9634) I
Normethadone (9635) I
Norpipanone (9636) I
Phenadoxone (9637) I
Phenampromide (9638) I
Phenoperidine (9641) I
Piritramide (9642) I
Proheptazine (9643) I
Properidine (9644) I
Racemoramide (9645) I
Trimeperidine (9646) I
Phenomorphan (9647) I
Propiram (9649) I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661) I
1- (2-Phenylethyl) -4-phenyl-4-acetoxypiperidine (9663) I
Tilidine (9750) I
Para-Fluorofentanyl (9812) I
3-Methylfentanyl (9813) I
Alpha-Methylfentanyl (9814) I
Acetyl-alpha-methylfentanyl (9815) I
Benzylfentanyl (9818) I
Beta-Hydroxyfentanyl (9830) I
Beta-Hydroxy-3-methylfentanyl (9831) I
Alpha-Methylthiofentanyl (9832) I
3-Methylthiofentanyl (9833) I
Thenylfentanyl (9834) I
Thiofentanyl (9835) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Glutethimide (2250) II
Nabilone (7379) II
1-Phenylcylohexylamine (7460) II
Phencyclidine (7471) II
Phenylacetone (8501) II
1-Piperidinocyclohexane-carbonitrile (8603) II
Alphaprodine (9010) II
Anileridine (9020) II
Cocaine (9041) II
Codeine (9050) II
Diprenorphine (9058) II
Etorphine HCL (9059) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ecgonine (9180) II
Ethylmorphine (9190) II
Hydrocodone (9193) II
Levomethorphan (9210) II
Levorphanol (9220) II
Isomethadone (9226) II
Meperidine (9230) II
Meperidine intermediate-A (9232) II
Meperidine intermediate-B (9233) II
Meperidine intermediate-C (9234) II
Metazocine (9240) II
Methadone (9250) II
Methadone intermediate (9254) II
Metopon (9260) II
Morphine (9300) II
Thebaine (9333) II
Dihydroetorphine (9334) II
Opium, raw (9600) II
Opium tincture (9630) II
Opium powered (9639) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Phenazocine (9715) II
Piminodine (9730) II
Racemethorphan (9732) II
Racemorphan (9733) II
Alfentanil (9737) II
Remifentanil (9739) II
[[Page 57929]] II
Sufentanil (9740) II
Carfentanil (9743) II
Bezitramide (9800) II
Fentanyl (9801) II
Moramide-intermediate (9802) II

The firm plans to manufacture small quantities of bulk material for use in reference standards.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of AccuStandard Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated AccuStandard Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of  Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.

Dated: September 17, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-25308 Filed 10-6-03; 8:45 am]
BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New